Molecular Imaging and Contrast Agent Database (MICAD)

MICAD is a key component of the NIH Common Fund (formerly NIH Roadmap); it is developed by the National Center for Biotechnology Information (NCBI), at the National Institutes of Health (NIH). More about MICAD »

After June 30 of 2013, new and revised chapters will no longer be uploaded to the MICAD website. However, the current chapters remain available online.

1444 agents currently listed. Latest update: June 27, 2013.

MICAD available through PubMed: MICAD chapters are now accessible through PubMed. To retrieve a list of all MICAD records, query PubMed for "Molecular Imaging and Contrast Agent Database (MICAD)"[book].

FDA Approved Contrast Agents: Download a list of FDA approved contrast agents (Latest update: January 2013).

Molecular Imaging Probes and Contrast Agents List: The MICAD staff has created the Molecular Imaging Probes and Contrast Agents List (MIP & CA List) by screening the PubMed/MedLine databases and other appropriate sources of such information. Only agents used in animal or human studies yielding in vivo data were selected for inclusion in the list. Although great care has been taken to accurately present all and only those imaging and contrast agents that fulfill the in vivo data criteria, this list is by no means considered complete. No one imaging modality has been given preference over the others and the omission of any agent(s) or the introduction of any errors in the list is purely unintentional. The MIP & CA List is subject to the same copyright and disclaimers as the rest of the MICAD content. Please read carefully the complete disclaimer information for MICAD before using the list. Download the list (Latest update: January 2013).